Atlas Trials

Trial on Lenalidomide Given as Maintenance Therapy for Relapsed Diffuse Large B Cell Lymphoma

Clinical trial NCT00799513 · COMPLETED

Trial details

NCT number
NCT00799513
Sponsor
IRCCS San Raffaele
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Diffuse Large B-cell Lymphoma
Start date
2009-03-01
Primary completion
2017-03-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.